Article
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
The Journal of biological chemistry - 11 Jun 2010
Faoro Leonardo, Singleton Patrick A, Cervantes Gustavo M, Lennon Frances E, Choong Nicholas W, Kanteti Rajani, Ferguson Benjamin D, Husain Aliya N, Tretiakova Maria S, Ramnath Nithya, Vokes Everett E, Salgia Ravi
Abstract excerpt
Non-small cell lung cancer (NSCLC) has a poor prognosis and improved therapies are needed. Expression of EphA2 is increased in NSCLC metastases. In this study, we investigated EphA2 mutations in NSCLC and examined molecular pathways involved in NSCLC. Tumor and cell line DNA was sequenced. One EphA2 mutation was modeled by expression in BEAS2B cells, and functional and biochemical studies were conducted. A G391R...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
